These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 9918934

  • 21. [Vaccination against hepatitis A].
    Giusti G, Russo M.
    Recenti Prog Med; 1992 Jun; 83(6):313-20. PubMed ID: 1323136
    [Abstract] [Full Text] [Related]

  • 22. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF, Chen TH.
    Vaccine; 2009 Nov 12; 27(48):6770-6. PubMed ID: 19735755
    [Abstract] [Full Text] [Related]

  • 23. Economic models of hepatitis A virus immunization.
    O'Connor JB, Imperiale TF, Singer ME.
    Hepatology; 1999 Jul 12; 30(1):343-5. PubMed ID: 10428627
    [No Abstract] [Full Text] [Related]

  • 24. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
    Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP.
    Pediatrics; 2007 Jan 12; 119(1):e22-9. PubMed ID: 17200247
    [Abstract] [Full Text] [Related]

  • 25. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico.
    Carlos F, Gómez JA, Anaya P, Romano-Mazzotti L.
    Hum Vaccin Immunother; 2016 Jan 12; 12(1):52-63. PubMed ID: 26503702
    [Abstract] [Full Text] [Related]

  • 26. [Studies on immunization strategy against hepatitis A in a highly prevalent area].
    Zhang Y, Ma J, Zhao S.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Sep 12; 32(5):295-6. PubMed ID: 10322776
    [Abstract] [Full Text] [Related]

  • 27. Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.
    Chapko MK, Yee HS, Monto A, Dominitz JA.
    Vaccine; 2010 Feb 17; 28(7):1726-31. PubMed ID: 20044051
    [Abstract] [Full Text] [Related]

  • 28. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M, Munshi SU, Nessa A, Ullah MS, Tabassum S, Islam MN.
    Indian J Med Microbiol; 2009 Feb 17; 27(1):48-50. PubMed ID: 19172060
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The prevalence and direct costs of pre-immunization testing for hepatitis A in general practice.
    Buckley D, Fahey T, Bevan G.
    Br J Gen Pract; 1996 Sep 17; 46(410):541-2. PubMed ID: 8917876
    [Abstract] [Full Text] [Related]

  • 31. Vaccinating Thai adolescents against hepatitis A: is it cost-effective?
    Soogarun S, Wiwanitkit V.
    Southeast Asian J Trop Med Public Health; 2002 Sep 17; 33 Suppl 3():145-8. PubMed ID: 12971496
    [Abstract] [Full Text] [Related]

  • 32. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
    Jacobs RJ, Koff RS, Meyerhoff AS.
    Am J Gastroenterol; 2002 Feb 17; 97(2):427-34. PubMed ID: 11866283
    [Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness of hepatitis A/B vaccine versus hepatitis B vaccine in public sexually transmitted disease clinics.
    Jacobs RJ, Meyerhoff AS.
    Sex Transm Dis; 2003 Nov 17; 30(11):859-65. PubMed ID: 14603096
    [Abstract] [Full Text] [Related]

  • 34. Cost-effectiveness of hepatitis A vaccination for adults in Belgium.
    Luyten J, Van de Sande S, de Schrijver K, Van Damme P, Beutels P.
    Vaccine; 2012 Sep 14; 30(42):6070-80. PubMed ID: 22858555
    [Abstract] [Full Text] [Related]

  • 35. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
    Bauch CT, Rao AS, Pham BZ, Krahn M, Gilca V, Duval B, Chen MH, Tricco AC.
    Vaccine; 2007 Feb 26; 25(10):1719-26. PubMed ID: 17229493
    [Abstract] [Full Text] [Related]

  • 36. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2005 May 26; 36(3):693-9. PubMed ID: 16124440
    [Abstract] [Full Text] [Related]

  • 37. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY, Billah K, Lieu TA, Weinstein MC.
    Am J Prev Med; 2006 Jun 26; 30(6):498-506. PubMed ID: 16704944
    [Abstract] [Full Text] [Related]

  • 38. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology.
    Hendrickx G, Van Herck K, Vorsters A, Wiersma S, Shapiro C, Andrus JK, Ropero AM, Shouval D, Ward W, Van Damme P.
    J Viral Hepat; 2008 Oct 26; 15 Suppl 2():1-15. PubMed ID: 18837827
    [Abstract] [Full Text] [Related]

  • 39. Hepatitis A infection in aircrews: risk of infection and cost-benefit analysis of hepatitis A vaccination.
    Gutersohn T, Steffen R, Van Damme P, Holdener F, Beutels P.
    Aviat Space Environ Med; 1996 Feb 26; 67(2):153-6. PubMed ID: 8834941
    [Abstract] [Full Text] [Related]

  • 40. [Prevention of hepatitis A and hepatitis B by vaccination].
    Buisson Y, Meyran M.
    Ann Gastroenterol Hepatol (Paris); 1995 Oct 26; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.